EP
NXTM

Elkfork Partners’s NxStage Medical Inc. NXTM Stock Holding History

Elkfork Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,872
Closed -$121K – 1046
2018
Q1 		$121K Sell
4,872
-14,756
-75% -$359K ﹤0.01% 911
2017
Q4 		$476K Sell
19,628
-14,056
-42% -$370K 0.01% 549
2017
Q3 		$930K Sell
33,684
-4,200
-11% -$112K 0.03% 338
2017
Q2 		$950K Sell
37,884
-12,628
-25% -$313K 0.03% 338
2017
Q1 		$1.35M Hold
50,512
– – 0.04% 286
2016
Q4 		$1.32M Buy
+50,512
New +$1.25M 0.04% 273

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Elkfork Partners's NXTM Position: Q2 2018 in Review

Elkfork Partners sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 4,872 shares — an estimated $121K sold.

Elkfork Partners first reported a position in NXTM in Q4 2016 and held it in 6 quarters. The position peaked at $1.35M in Q1 2017. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • Elkfork Partners reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
  • Elkfork Partners sold 4,872 NxStage Medical Inc. shares in Q2 2018, an estimated $121K.
  • Elkfork Partners first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 6 quarters.
  • Elkfork Partners's NxStage Medical Inc. position peaked at $1.35M in Q1 2017.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on Elkfork Partners's 13F filing for Q2 2018, filed 14 Aug 2018.